Abstract
To investigate the effect of intensive physiotherapy on disease activity and serum levels of adipocytokines in patients with ankylosing spondylitis (AS). Twenty-six patients with AS were included in this study. Intensive physiotherapy was performed twice a week for a period of 3 months. The Bath AS Disease Activity Index (BASDAI) and the Bath AS Functional Index (BASFI) were assessed at inclusion and after 3 months. Leptin, adiponectin, resistin and visfatin serum levels were analysed by ELISA assays. Patients had mild to moderate disease activity. Baseline levels of adipocytokines did not correlate with indicators of disease activity, functional status or acute-phase reactants. After the 3 months of intensive physiotherapy, BASDAI significantly decreased from 2.98 to 1.8 (p = 0.01) and BASFI improved from 2.31 to 1.37 (p = 0.05), while there were no changes in serum levels of CRP, ESR and adipocytokines. In addition, baseline levels of adipocytokines did not predict the change of disease activity or functional ability. Intensive physiotherapy effectively reduces all clinical measures of disease activity, but it is not associated with a significant change in acute-phase reactants or serum levels of adipocytokines.
Similar content being viewed by others
References
Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369(9570):1379–1390
Braun J, Pham T, Sieper J, Davis J, van der Linden S, Dougados M, van der Heijde D, ASAS Working Group (2003) International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 62(9):817–824
Nghiem FT, Donohue JP (2008) Rehabilitation in ankylosing spondylitis. Curr Opin Rheumatol 20(2):203–207
Dagfinrud H, Kvien TK, Hagen KB (2005) The Cochrane review of physiotherapy interventions for ankylosing spondylitis. J Rheumatol 32(10):1899–1906
Gualillo O, González-Juanatey JR, Lago F (2007) The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives. Trends Cardiovasc Med 17(8):275–283
Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6:772–783
Stofkova A (2010) Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity. Endocrine Regulations 44(1):25–36
Bokarewa M, Bokarew D, Hultgren O, Tarkowski A (2003) Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis 62:952–956
Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A (2005) Resistin, an adipokine with potent proinflammatory properties. J Immunol 174(9):5789–5795
Filková M, Haluzík M, Gay S, Senolt L (2009) The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol 133(2):157–170
Senolt L, Pavelka K, Housa D, Haluzík M (2006) Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine 35(5–6):247–252
Ehling A, Schaffler A, Herfarth H, Tarner IH, Anders S, Distler O et al (2006) The potential of adiponectin in driving arthritis. J Immunol 176:4468–4478
Brentano F, Schorr O, Ospelt C, Stanczyk J, Gay RE, Gay S, Kyburz D (2007) Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis Rheum 56(9):2829–2839
Otero M, Lago R, Gomez R et al (2006) Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65:1198–1201
Senolt L, Housa D, Vernerová Z, Jirásek T, Svobodová R, Veigl D, Anderlová K, Müller-Ladner U, Pavelka K, Haluzík M (2007) Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis 66(4):458–463
Park MC, Lee SW, Choi ST, Park YB, Lee SK (2007) Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis. Scand J Rheumatol 36(2):101–106
Toussirot E, Streit G, Nguyen NU et al (2007) Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis. Metabolism 56(10):1383–1389
Jones TE, Basilio JL, Brophy PM, McCammon MR, Hickner RC (2009) Long-term exercise training in overweight adolescents improves plasma peptide YY and resistin. Obesity (Silver Spring) 17(6):1189–1195
Varady KA, Bhutani S, Church EC, Phillips SA (2010) Adipokine responses to acute resistance exercise in trained and untrained men. Med Sci Sports Exerc 42(3):456–462
Sari I, Okan T, Akar S et al (2006) Impaired endothelial function in patients with ankylosing spondylitis. Rheumatol Oxford 45(3):283–286
van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–368
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21(12):2286–2291
Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol 21(12):2281–2285
Kasapis C, Thompson PD (2005) The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 45(10):1563–1569
Lundberg IE, Nader GA (2008) Molecular effects of exercise in patients with inflammatory rheumatic disease. Nat Clin Pract Rheumatol 4(11):597–604
Karapolat H, Akkoc Y, Sari I et al (2008) Comparison of group-based exercise versus home-based exercise in patients with ankylosing spondylitis: effects on bath ankylosing spondylitis indices, quality of life and depression. Clin Rheumatol 27(6):695–700
Sweeney S, Taylor G, Calin A (2002) The effect of a home based exercise intervention package on outcome in ankylosing spondylitis: a randomized controlled trial. J Rheumatol 29(4):763–766
Acknowledgments
This work was supported by MH CR—research project nos. 00023728 and by MSM 0021620864
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hulejová, H., Levitová, A., Kuklová, M. et al. No effect of physiotherapy on the serum levels of adipocytokines in patients with ankylosing spondylitis. Clin Rheumatol 31, 67–71 (2012). https://doi.org/10.1007/s10067-011-1773-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-011-1773-7